Showing 3311-3320 of 5621 results for "".
- State Investment to Fund first College of Optometry in Georgiahttps://modernod.com/news/state-investment-to-fund-first-college-of-optometry-in-georgia/2487311/Georgia Southern University has secured nearly $40 million in state funding to advance several transformative projects, including the establishment of the state's first College of Optometry. The funding, made through Georgia's Amended Fiscal Year 2026 Budget (HB 973), will support the reno
- Rayner Launches Optiesis Cohesive OVD Familyhttps://modernod.com/news/rayner-launches-optiesis-cohesive-ovd-family/2487302/Rayner announced the launch of Optiesis Cohesive, a proprietary new ophthalmic viscosurgical device (OVD), marking an expansion of its OVD portfolio and surgical product offering. According to the company, Optiesis Cohesive is
- Cure Blindness Project Releases 2025 Impact Report Highlighting Global Reach and Restored Visionhttps://modernod.com/news/cure-blindness-project-releases-2025-impact-report-highlighting-global-reach-and-restored-vision/2487240/Cure Blindness Project has released its 2025 Impact Report, detailing significant progress in expanding access to eye care and preventing avoidable blindness worldwide. The re
- Lumenis Expands Peer-to-Peer Education With 2026 Accelerate Series for Eye Care Professionalshttps://modernod.com/news/lumenis-expands-peer-to-peer-education-with-2026-accelerate-series-for-eye-care-professionals/2487031/Lumenis announced the launch of its 2026 Accelerate education series, a nationwide peer-to-peer learning initiative designed to help eye care professionals expand procedural services, strengthen clinical confidence, and integrate advanced therapeutic technologies in
- Johnson & Johnson Showcases New Vision Research at ARVO 2026https://modernod.com/news/johnson-johnson-showcases-new-vision-research-at-arvo-2026/2486943/Johnson & Johnson Vision is presenting a broad range of new clinical and preclinical data at the 2026 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Denver, highlighting advancements across IOLs, contact lenses, and myopia manageme
- Early Screening and Outdoor Activity Key to Tackling Childhood Myopia, Italian Study Findshttps://modernod.com/news/early-screening-and-outdoor-activity-key-to-tackling-childhood-myopia-italian-study-finds/2486939/Key Takeaways Early and regular eye screenings—starting around age 3—are critical for detecting and managing childhood myopia before it progresses
- Theialife Appoints Thomas Ruggia as President and CEOhttps://modernod.com/news/theialife-appoints-thomas-ruggia-as-president-and-ceo/2486807/Theialife announced the appointment of Thomas Ruggia as President and Chief Executive Officer. Mr. Ruggia will oversee the company’s development, operational, and corporate strategy as it approaches key milestones, including the planned initiation of phase 3 clinic
- Focus A-Eye to Launch Inaugural AI Summit Advancing the Future of Ophthalmologyhttps://modernod.com/news/focus-a-eye-to-launch-inaugural-ai-summit-advancing-the-future-of-ophthalmology/2486795/Focus A-Eye, a specialized medical education and innovation forum dedicated to advancing the application of AI in ophthalmology, has announced the launch of its inaugural Focus A-Eye Summit, set to take place on Saturday, May 2, 2026, in Denver, Colorado.
- Burnout Rising Among VA Optometrists, New Study Warnshttps://modernod.com/news/burnout-rising-among-va-optometrists-new-study-warns/2486597/Key Takeaways Burnout among VA optometrists increased substantially from 2018 to 2024, approaching nearly half of providers in recent years
- Tenpoint Therapeutics Appoints Stephen S. Lane, MD, as Chief Medical Officerhttps://modernod.com/news/tenpoint-therapeutics-appoints-stephen-s-lane-md-as-chief-medical-officer/2486536/Tenpoint Therapeutics announced the appointment of Stephen S. Lane, MD, as Chief Medical Officer (CMO). In this role, Dr. Lane will join the company’s executive leadership team and oversee clinical development strategy, medical affairs, and pharmacovigilance. <